ATA279787A - Verwendung eines oestradiolderivates zur herstellung eines pharmazeutischen praeparates zur unterdrueckung der immunreaktion - Google Patents

Verwendung eines oestradiolderivates zur herstellung eines pharmazeutischen praeparates zur unterdrueckung der immunreaktion

Info

Publication number
ATA279787A
ATA279787A AT2797/87A AT279787A ATA279787A AT A279787 A ATA279787 A AT A279787A AT 2797/87 A AT2797/87 A AT 2797/87A AT 279787 A AT279787 A AT 279787A AT A279787 A ATA279787 A AT A279787A
Authority
AT
Austria
Prior art keywords
suppressing
producing
pharmaceutical preparation
immune reaction
oestradiol
Prior art date
Application number
AT2797/87A
Other languages
English (en)
Other versions
AT393222B (de
Inventor
Kiro Asano
Tadahiro Matsudaira
Humio Tamura
Yoichi Suzuki
Hisayuki Wada
Original Assignee
Kureha Chemical Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Chemical Ind Co Ltd filed Critical Kureha Chemical Ind Co Ltd
Publication of ATA279787A publication Critical patent/ATA279787A/de
Application granted granted Critical
Publication of AT393222B publication Critical patent/AT393222B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT2797/87A 1986-11-12 1987-10-22 Verwendung eines oestradiolderivates zur herstellung eines pharmazeutischen praeparates zur unterdrueckung der immunreaktion AT393222B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61268940A JPH0621072B2 (ja) 1986-11-12 1986-11-12 エストラジオ−ル誘導体よりなる免疫調節剤

Publications (2)

Publication Number Publication Date
ATA279787A true ATA279787A (de) 1991-02-15
AT393222B AT393222B (de) 1991-09-10

Family

ID=17465393

Family Applications (1)

Application Number Title Priority Date Filing Date
AT2797/87A AT393222B (de) 1986-11-12 1987-10-22 Verwendung eines oestradiolderivates zur herstellung eines pharmazeutischen praeparates zur unterdrueckung der immunreaktion

Country Status (9)

Country Link
US (1) US4885290A (de)
JP (1) JPH0621072B2 (de)
AT (1) AT393222B (de)
AU (1) AU585179B2 (de)
CH (1) CH674465A5 (de)
DE (1) DE3736691A1 (de)
GB (2) GB2197588B (de)
IT (1) IT1223323B (de)
NL (1) NL8702598A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0794377B2 (ja) * 1987-07-22 1995-10-11 呉羽化学工業株式会社 エストラジオール誘導体を含有する注射剤
CA1335792C (en) * 1987-08-18 1995-06-06 Chaim O. Jacob Method and dosage form using an antagonist to gamma interferon to control mhc-associated autoimmune disease
JPH04356428A (ja) * 1991-02-26 1992-12-10 Keisuke Hirasawa 免疫抑制剤
JP2520074B2 (ja) * 1992-06-11 1996-07-31 呉羽化学工業株式会社 新規なエストラジオ―ル誘導体−クロラムブチル結合体、その製造方法、及び医薬製剤
WO1994022451A1 (en) * 1993-04-07 1994-10-13 Oklahoma Medical Research Foundation Selective regulation of b lymphocyte precursors by hormones
JPH07101977A (ja) * 1993-10-05 1995-04-18 Kureha Chem Ind Co Ltd ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175468A (en) * 1967-10-19 1969-12-23 Merck Ag E Pharmaceutical Compositions
US4029778A (en) * 1969-01-23 1977-06-14 Aktiebolaget Leo Cortical steroid nitrogen mustard compositions and treatment therewith
GB1558472A (en) * 1976-01-22 1980-01-03 Leo Ab 17-esters of 17- hydroxy gestogens
GB1527161A (en) * 1976-02-19 1978-10-04 Leo A Enol esters of steroids
US4096254A (en) * 1976-05-10 1978-06-20 Richardson-Merrell Inc. Method of treating the symptoms of menopause and osteoporosis
JPS5822120B2 (ja) * 1978-03-31 1983-05-06 大塚製薬株式会社 3−0−(β−D−グルクロノピラノシル)−ソ−ヤサポゲノ−ルB
US4261910A (en) * 1978-08-14 1981-04-14 Kureha Kagaku Kogyo Kabushiki Kaisha Process for the preparation of Chlorambucil derivatives
GB2070597B (en) * 1980-02-15 1983-07-27 Taiho Pharmaceutical Co Ltd Sulphonium compounds
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
FR2494697A1 (fr) * 1980-11-21 1982-05-28 Roussel Uclaf Nouveaux derives steroides 3-amines, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
GB8413191D0 (en) * 1984-05-23 1984-06-27 Beecham Group Plc Pharmaceutical composition
JPS6450919A (en) * 1987-08-21 1989-02-27 Sharp Kk Photosensing element

Also Published As

Publication number Publication date
AU8012187A (en) 1988-05-19
CH674465A5 (de) 1990-06-15
US4885290A (en) 1989-12-05
NL8702598A (nl) 1988-06-01
IT8722414A0 (it) 1987-10-27
GB9013267D0 (en) 1990-08-08
GB2197588B (en) 1991-03-13
GB8725267D0 (en) 1987-12-02
JPH0621072B2 (ja) 1994-03-23
DE3736691A1 (de) 1988-05-26
AU585179B2 (en) 1989-06-08
GB2197588A (en) 1988-05-25
AT393222B (de) 1991-09-10
DE3736691C2 (de) 1991-05-23
JPS63122625A (ja) 1988-05-26
GB2232353A (en) 1990-12-12
IT1223323B (it) 1990-09-19
GB2232353B (en) 1991-03-20

Similar Documents

Publication Publication Date Title
NO862734D0 (no) Fremgangsmaate for fremstilling av hyaluronsyreestere.
FI893100L (fi) Analogiamenetelmä asyylideoksiribonukleosidijohdannaisten valmistamiseksi
ATA164187A (de) Verfahren zur herstellung eines pharmazeutischen pulvers
NO170540C (no) En analogifremgangsmaate for fremstilling av 1-hydroksy-2-pyridoner
FI890388L (fi) Menetelmä (S)-ketoprofeenin valmistamiseksi
DE68918016D1 (de) Verfahren zur Herstellung eines Dimethyltetralins.
ATA245988A (de) Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung
FI91961C (fi) Menetelmä (S)- -etyyli-2-okso-1-pyrrolidiiniasetamidin valmistamiseksi
NO883503D0 (no) Fremgangsmaate for fremstilling av aminoalkoksyfenyl-derivater.
FI93106C (fi) Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi
NO873923D0 (no) Fremgangsmaate for fremstilling av et medisinsk hudpreparat
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
FI895983A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi
PT88682A (pt) A process for the preparation of pharmaceutical compositions containing a piperidinoalkanol-decongestant combination
NO172351C (no) Fremgangsmaate for fremstilling av glykopeptider
NO880294L (no) Fremgangsmaate for fremstilling av tetrahydrofuranderivater
NO167980C (no) Analogifremgangsmaate for fremstilling av tienoimidazol-derivater.
TR23355A (tr) Naftasen'lerin hazirlanmasi icin usul
ATA207887A (de) Verfahren zur herstellung eines pharmazeutischen nicorandilpraeparats zur perkutanen absorption
FI891191A7 (fi) Menetelmä 3-eksometyleeni-kefam-johdannaisten valmistamiseksi
NO874780D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater.
NO884545D0 (no) Fremgangsmaate for fremstilling av alfa-l-aspartyl-l-fenylalaninmethylester.
PT86666A (pt) Process for the preparation of pilocarpine by products
NO872683D0 (no) Fremgangsmaate for fremstilling av difenylazometinderivater
ATA262687A (de) Verwendung eines 8-chlorobenzothiazepins zur herstellung eines arzneimittels

Legal Events

Date Code Title Description
ELA Expired due to lapse of time
ELJ Ceased due to non-payment of the annual fee